Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The functional heart is comprised of distinct mesoderm-derived lineages including cardiomyocytes, endothelial cells and vascular smooth muscle cells. Studies in the mouse embryo and the mouse embryonic stem cell differentiation model have provided evidence indicating that these three lineages develop from a common Flk-1(+) (kinase insert domain protein receptor, also known as Kdr) cardiovascular progenitor that represents one of the earliest stages in mesoderm specification to the cardiovascular lineages. To determine whether a comparable progenitor is present during human cardiogenesis, we analysed the development of the cardiovascular lineages in human embryonic stem cell differentiation cultures. Here we show that after induction with combinations of activin A, bone morphogenetic protein 4 (BMP4), basic fibroblast growth factor (bFGF, also known as FGF2), vascular endothelial growth factor (VEGF, also known as VEGFA) and dickkopf homolog 1 (DKK1) in serum-free media, human embryonic-stem-cell-derived embryoid bodies generate a KDR(low)/C-KIT(CD117)(neg) population that displays cardiac, endothelial and vascular smooth muscle potential in vitro and, after transplantation, in vivo. When plated in monolayer cultures, these KDR(low)/C-KIT(neg) cells differentiate to generate populations consisting of greater than 50% contracting cardiomyocytes. Populations derived from the KDR(low)/C-KIT(neg) fraction give rise to colonies that contain all three lineages when plated in methylcellulose cultures. Results from limiting dilution studies and cell-mixing experiments support the interpretation that these colonies are clones, indicating that they develop from a cardiovascular colony-forming cell. Together, these findings identify a human cardiovascular progenitor that defines one of the earliest stages of human cardiac development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CMs can reliably be derived from human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) using protocols that involve timed application of GFs or small molecules, that are designed to recapitulate developmental pathways.”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [148]
Citations
Cites
Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., Reinecke, H., Xu, C., Hassanipour, M., Police, S., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1327 · Cited by 2,206
Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse.
Winnier, G., Blessing, M., Labosky, P. A., & Hogan, B. L. (1995) · Genes & Development · doi:10.1101/gad.9.17.2105 · Cited by 1,788
Cai, C.-L., Liang, X., Shi, Y., Chu, P.-H., Pfaff, S. L., Chen, J., & Evans, S. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00363-0 · Cited by 1,610
Moretti, A., Caron, L., Nakano, A., Lam, J. T., Bernshausen, A., Chen, Y., Qyang, Y., Bu, L., Sasaki, M., Martin-Puig, S., et al. (2006) · Cell · doi:10.1016/j.cell.2006.10.029 · Cited by 1,038
Bearzi, C., Rota, M., Hosoda, T., Tillmanns, J., Nascimbene, A., De Angelis, A., Yasuzawa-Amano, S., Trofimova, I., Siggins, R. W., LeCapitaine, N., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706760104 · Cited by 980
Requirement for Wnt3 in vertebrate axis formation
Liu, P., Wakamiya, M., Shea, M. J., Albrecht, U., Behringer, R. R., & Bradley, A. (1999) · Nature Genetics · doi:10.1038/11932 · Cited by 901
Lints, T. J., Parsons, L. M., Hartley, L., Lyons, I., & Harvey, R. P. (1993) · Development · doi:10.1242/dev.119.2.419 · Cited by 861
Conlon, F. L., Lyons, K. M., Takaesu, N., Barth, K. S., Kispert, A., Herrmann, B., & Robertson, E. J. (1994) · Development · doi:10.1242/dev.120.7.1919 · Cited by 770
Kattman, S. J., Huber, T. L., & Keller, G. M. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.10.002 · Cited by 729
Self-citationRole of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum
de la Pompa, J. L., Timmerman, L. A., Takimoto, H., Yoshida, H., Elia, A. J., Samper, E., Potter, J., Wakeham, A., Marengere, L., Langille, B. L., et al. (1998) · Nature · doi:10.1038/32419 · Cited by 660
Cited by
Items 601–700 of 1,000
Prowse, A. B. J., Timmins, N. E., Yau, T. M., Li, R., Weisel, R. D., Keller, G. M., & Zandstra, P. W. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.08.005 · Cited by 34
Self-citationMicro-Arrayed Human Embryonic Stem Cells-Derived Cardiomyocytes for In Vitro Functional Assay
Serena, E., Cimetta, E., Zatti, S., Zaglia, T., Zagallo, M., Keller, G. M., & Elvassore, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048483 · Cited by 34
“Human cardiomyocytes (hCMs) were derived from HES2 cell line (Wisconsin International Stem Cell Bank) as previously described by Yang et al [21].”
MethodSelf-citationIshida, H., Saba, R., Kokkinopoulos, I., Hashimoto, M., Yamaguchi, O., Nowotschin, S., Shiraishi, M., Ruchaya, P. J., Miller, D. C., Harmer, S. C., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.050 · Cited by 32
“…studies have revealed that both KDR+/PDGFRA+ and KDRlow+/ KITneg cell populations contain highly enriched multipotent pro- genitors producing not only cardiomyocytes but also endothelial and smooth muscle cells in mouse and human, respectively (Kattman et al., 2006, 2011; Yang et al., 2008).”
BackgroundResultInfluentialGeneration of Cardiomyocytes From Vascular Adventitia-Resident Stem Cells
Mekala, S. R., Wörsdörfer, P., Bauer, J., Stoll, O., Wagner, N., Reeh, L., Löw, K., Eckner, G., Kwok, C. K., Wischmeyer, E., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.312526 · Cited by 35
Pluripotent Stem Cell-Derived Cardiomyocyte Transplantation for Heart Disease Treatment
Kadota, S., & Shiba, Y. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1171-3 · Cited by 33
Fernandes, T. G., Duarte, S. T., Ghazvini, M., Gaspar, C., Santos, D. C., Porteira, A. R., Rodrigues, G., Haupt, S., Rombo, D. M., Armstrong, J., et al. (2015) · Biotechnology Journal · doi:10.1002/biot.201400751 · Cited by 34
Mehta, A. K., Ramachandra, C. J. A., Sequiera, G. L., Sudibyo, Y., Nandihalli, M., Yong, P. J. A., Koh, C. H., & SHIM, W. S. N. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.06.011 · Cited by 32
Lessons for cardiac regeneration and repair through development
Alexander, J. M., & Bruneau, B. G. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.06.003 · Cited by 32
“Interestingly, in humans low expression of the Flk1 ortholog KDR and lack of c-kit (KDRlow/c-kit−) marks a cell population with cardiogenic potential [27].”
BackgroundFgf is required to regulate anterior–posterior patterning in the Xenopus lateral plate mesoderm
Deimling, S. J., & Drysdale, T. A. (2011) · Mechanisms of Development · doi:10.1016/j.mod.2011.06.002 · Cited by 38
“In mammals, individual stem cells that can give rise to cardiomyocytes, endothelial cells and smooth muscle cells have also been identified in the early embryo (Ferdous et al., 2009; Martinez-Estrada et al., 2010; Moretti et al., 2006; Yang et al., 2008).”
Stemming heart failure with cardiac‐ or reprogrammed‐stem cells
Tateishi, K., Takehara, N., Matsubara, H., & Oh, H. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00487.x · Cited by 37
Discovery of a Small-Molecule BMP Sensitizer for Human Embryonic Stem Cell Differentiation
Feng, L., Cook, B. D., Tsai, S., Zhou, T., LaFlamme, B. A., Evans, T., & Chen, S. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.066 · Cited by 32
“When cells are allowed to differentiate as embryoid bodies, the addition of BMP4 directs mouse and human ESC differentiation to mesoderm, which subsequently generates beating cardiomyocytes (Cao et al., 2013; Kattman et al., 2011; Yang et al., 2008).”
BackgroundMaturation of Human Stem Cell-derived Cardiomyocytes in Biowires Using Electrical Stimulation
Sun, X., & Nunes, S. S. (2017) · Journal of Visualized Experiments · doi:10.3791/55373 · Cited by 32
Fabre, K. M., Delsing, L., Hicks, R., Colclough, N., Crowther, D. C., & Ewart, L. C. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.09.009 · Cited by 32
The Histone Methyltransferase Inhibitor BIX01294 Enhances the Cardiac Potential of Bone Marrow Cells
Mezentseva, N. V., Yang, J., Kaur, K., Iaffaldano, G., Rémond, M. C., Eisenberg, C. A., & Eisenberg, L. M. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0181 · Cited by 32
“Neither Wnt11 nor other factors that are known to contribute to cardiomyocyte differentiation (e.g., BMP4, FGF2) have shown ability, either individually or in combination, to drive bona fide cardiac progenitors to form fully differentiated cardiomyocytes in culture [90,91].”
Verma, V., Purnamawati, K., Manasi, & SHIM, W. S. N. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.01.027 · Cited by 31
Skelton, R. J. P., Brady, B., Khoja, S., Sahoo, D., Engel, J. D., Arasaratnam, D., Saleh, K. K., Abilez, O. J., Zhao, P., Stanley, E. G., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.11.006 · Cited by 34
Building a new strategy for treating heart failure using Induced Pluripotent Stem Cells
Miyagawa, S., & Sawa, Y. (2018) · Journal of Cardiology · doi:10.1016/j.jjcc.2018.05.002 · Cited by 32
Wu, Q., Xue, R., Zhao, Y., Ramsay, K., Wang, E. Y., Savoji, H., Veres, T., Cartmell, S. H., & Radisic, M. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.10.019 · Cited by 42
“Human induced pluripotent stem cells (hiPSC) cardiomyocytes (CMs) were differentiated from hiPSC line BJ1D (a kind gift from William Stanford, Ottawa Hospital-Institute Research) by monolayer differentiation protocols [36,37] as we described [27].”
MethodHerrmann, F. E., Bundschu, K., Kühl, S. J., & Kühl, M. (2011) · Developmental Dynamics · doi:10.1002/dvdy.22776 · Cited by 32
“Murine heart development starts during gastrulation when cells of the anterior mesoderm form a common cardiovascular progenitor cell (CPC) population (Kattman et al., 2006; Moretti et al., 2006; Yang et al., 2008).”
BackgroundMethods of Cell Purification: A Critical Juncture for Laboratory Research and Translational Science
Amos, P. J., Çağavi, E., & Qyang, Y. (2011) · Cells Tissues Organs · doi:10.1159/000331390 · Cited by 37
“Some commonly used surface markers for cardiac progenitor cell purification are cellular prion protein, SSEA1, and KDR [Yang et al., 2008; Blin et al., 2010; Hidaka et al., 2010].”
BackgroundMethodStem Cells: The Game Changers of Human Cardiac Disease Modelling and Regenerative Medicine
Parrotta, E. I., Scalise, S., Scaramuzzino, L., & Cuda, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225760 · Cited by 34
“FGF2, FGF2, BMP4, VEGFA, Dorsomorphin, SB431542, DKK1 Kehat et al. 2001 [89] BMP4, Activin A, bFGF, VEGF, DKK1 Kattman et al. 2011 [90] FGF2, FGF2, BMP4, IWR1, Triiodothyronine Yang et al. 2008 [91] Willems et al. 2011 [92] Activin A, bFGF, BMP4, SCF, VEGF, LI-BEL Elliott et al. 2011 [93] BMP4, Activin A, bFGF, VEGF,…”
InfluentialBreckwoldt, K., Weinberger, F., & Eschenhagen, T. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.11.010 · Cited by 37
“development [72] and further technical advances now routinely give rise to a cardiomyocyte yield of up to N90% [73–75], making the availability of sufficient numbers of cardiomyocytes for human therapy increasingly realistic.”
BackgroundCell surface markers for immunophenotyping human pluripotent stem cell-derived cardiomyocytes
Boheler, K. R., & Poon, E. N.-Y. (2021) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02549-8 · Cited by 36
Strategies for the vascular patterning of engineered tissues for organ repair
Janson, K. D., Parkhideh, S., Swain, J. W. R., Weaver, J. D., Hartgerink, J. D., & Veiseh, O. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01420-w · Cited by 35
“ESCs, including vascular progenitor cells 77–81 , endothelial cells 82 and SMCs 83–85 , have been used successfully for the past two decades to generate the cellular components of the vasculature.”
Kempf, H., Lecina, M., Ting, S., Zweigerdt, R., & Oh, S. K. W. (2011) · Stem Cell Research · doi:10.1016/j.scr.2011.06.001 · Cited by 30
Exogenous Expression of Human apoA-I Enhances Cardiac Differentiation of Pluripotent Stem Cells
Ng, K., Lee, Y.-K., Lai, W., Chan, Y.-C., Fung, M., Tse, H., & Siu, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019787 · Cited by 30
Robust pluripotent stem cell expansion and cardiomyocyte differentiationviageometric patterning
Myers, F. B., Silver, J. S., Zhuge, Y., Beygui, R. E., Zarins, C. K., Lee, L. P., & Abilez, O. J. (2013) · Integrative Biology · doi:10.1039/c2ib20191g · Cited by 30
Martewicz, S., Serena, E., Zatti, S., Keller, G. M., & Elvassore, N. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.10.011 · Cited by 34
Self-citationWaas, M., Weerasekera, R., Kropp, E. M., Romero‐Tejeda, M., Poon, E. N.-Y., Boheler, K. R., Burridge, P. W., & Gundry, R. L. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.12.016 · Cited by 33
“, 2018) and markers of cardiomyogenic progenitors (Dubois et al., 2011; Yang et al., 2008) that can be helpful in assessing cell identity.”
BackgroundHalloin, C., Schwanke, K., Löbel, W., Franke, A., Szepes, M., Biswanath, S., Wunderlich, S., Merkert, S., Weber, N., Osten, F., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.09.001 · Cited by 36
Zhang, J., Gregorich, Z. R., Tao, R., Kim, G. C., Lalit, P. A., Carvalho, J. L., Markandeya, Y. S., Mosher, D. F., Palecek, S. P., & Kamp, T. J. (2022) · eLife · doi:10.7554/elife.69028 · Cited by 30
Zhu, K., Bao, X., Wang, Y., Lu, T., & Zhang, L. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113970 · Cited by 31
Induced Pluripotent Stem Cells in Cardiovascular Medicine
Egashira, T., Yuasa, S., & Fukuda, K. (2011) · Stem Cells International · doi:10.4061/2011/348960 · Cited by 33
Liu, J., Zhang, Z., Liu, Y., Guo, C., Gong, Y., Shi, Y., Ma, M., Li, Z., Gao, W., & He, Z. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0031 · Cited by 31
“Significantly, cardiac specification by producing 40% * 50% CMs can be induced from ES cells with the Wnt inhibitor Dkk1 [19].”
Abilez, O. J. (2012) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2012.6346197 · Cited by 30
“Our differentiation method used 50 ng/mL Activin A (Day 0), 5 ng/mL BMP-4 (Days 1-3), and 150 ng/mL Dkk-1 (Days 5-9) adapted from previously described methods [15, 16] and shown in Fig.”
MethodPasquier, J., Gupta, R., Rioult, D., Hoarau-Véchot, J., Courjaret, R. J., Machaca, K., Suwaidi, J. M. S. A., Stanley, E. G., Rafii, S., Elliott, D. A., et al. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.01.001 · Cited by 32
Engineered Maturation Approaches of Human Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes
Ge, F., Wang, Z., & Xi, J. (2019) · Cells · doi:10.3390/cells9010009 · Cited by 29
Rai, M., Walthall, J. M., Hu, J., & Hatzopoulos, A. K. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0326 · Cited by 29
A Chemical Biology Approach to Myocardial Regeneration
Willems, E., Lanier, M. C., Forte, E., Lo, F., Cashman, J. R., & Mercola, M. A. (2011) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-011-9270-6 · Cited by 34
“Judicious testing of such factors by several groups has led to optimized defined conditions for production of cardiomyocytes [10, 12, 13 ].”
BackgroundStem Cell Therapy of Myocardial Infarction: A Promising Opportunity in Bioengineering
Jiang, B., Yan, L., Shamul, J. G., Hakun, M., & He, X. (2020) · Advanced Therapeutics · doi:10.1002/adtp.201900182 · Cited by 31
Human DC3 Antigen Presenting Dendritic Cells From Induced Pluripotent Stem Cells
Satoh, T., Toledo, M. A. S., Böhnke, J., Olschok, K., Flosdorf, N., Götz, K., Küstermann, C., Sontag, S., Seré, K., Koschmieder, S., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.667304 · Cited by 30
Selvakumar, D., Reyes, L., & Chong, J. J. H. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01666-9 · Cited by 30
Miyagawa, S., Fukushima, S., Imanishi, Y., Kawamura, T., Mochizuki‐Oda, N., Masuda, S., & Sawa, Y. (2016) · Current Gene Therapy · doi:10.2174/1566523216666160119094143 · Cited by 30
“At stage 1, activin A and BMP4 were added to upregulate WNT signaling proteins that induce mesodermal differentiation, and then, at stage 2 the WNT inhibitor DKK1 was added to specify cardiac mesoderm with addition of VEGF or bFGF that promotes expansion and maturation of cells of cardiac lineage [16].”
BackgroundLi, Y., Lin, B., & Yang, L. (2015) · Scientific Reports · doi:10.1038/srep09758 · Cited by 29
Self-citationErñst, P., Bidwell, P. A., Dora, M., Thomas, D. D., & Kamdar, F. D. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.986107 · Cited by 30
Bioderived Nanoparticles for Cardiac Repair
Cui, X., Guo, J., Yuan, P., Dai, Y., Du, P., Yu, F., Sun, Z., Zhang, J., Cheng, K., & Tang, J. (2024) · ACS Nano · doi:10.1021/acsnano.3c07878 · Cited by 30
Multipotent Progenitor Cells in Regenerative Cardiovascular Medicine
Lam, J. T., Moretti, A., & Laugwitz, K. (2009) · Pediatric Cardiology · doi:10.1007/s00246-009-9450-1 · Cited by 31
“Recent work from the same group has demonstrated that a comparable progenitor is present during human cardiogenesis [71].”
BackgroundThe Cardiogenic Niche as a Fundamental Building Block of Engineered Myocardium
Christalla, P., Hudson, J. E., & Zimmermann, W. (2011) · Cells Tissues Organs · doi:10.1159/000331407 · Cited by 30
Kammili, R. K., Taylor, D. G., Xia, J., Osuala, K. O., Thompson, K., Menick, D. R., & Ebert, S. N. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0308 · Cited by 28
“Basic and clinical research on cardiac applications for stem cells has intensi-fi ed in recent years and much progress has been made [ 4–8 ], yet there is still a great deal of basic information about stem cells and their behavior that is lacking [ 9–11 ].”
Budniatzky, I., & Gepstein, L. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0163 · Cited by 33
Zhang, X., Cao, H., Bai, S., Huo, W., & Ma, Y. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.02.002 · Cited by 29
Lin, Y., Liu, H., Klein, M. G., Ostrominski, J. W., Hong, S. G., Yada, R. C., Chen, G., Navarengom, K., Schwartzbeck, R., San, H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24074-y · Cited by 29
Accelerated Coronary Angiogenesis by Vegfr1-Knockout Endocardial Cells
Zhang, Z., & Zhou, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070570 · Cited by 31
Hayano, M., Makiyama, T., Kamakura, T., Watanabe, H., Sasaki, K., Funakoshi, S., Wuriyanghai, Y., Nishiuchi, S., Harita, T., Yamamoto, Y., et al. (2017) · Circulation Journal · doi:10.1253/circj.cj-17-0064 · Cited by 28
Liu, F., Bhang, S. H., Arentson, E., Sawada, A., Kim, C. K., Kang, I., Yu, J., Sakurai, N., Kim, S. H., Yoo, J. J., et al. (2013) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.06.005 · Cited by 29
“…from ESCs or embryos can generate hematopoietic, endothelial, and smooth muscle cells as well as cardiac cells (Choi et al., 1998; Faloon et al., 2000; Yamashita et al., 2000; Ema et al., 2003; Huber et al., 2004; Kennedy et al., 2007; Kattman et al., 2006; Moretti et al., 2006; Yang et al., 2008).”
BackgroundIdentification of cardiovascular lineage descendants at single-cell resolution
Li, G., Plonowska‐Hirschfeld, K. A., Rajarajan, K., Sturzu, A. C., & Wu, S. M. (2015) · Development · doi:10.1242/dev.116897 · Cited by 27
de Peppo, G. M., & Marolt, D. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt317 · Cited by 29
Heart‐on‐a‐Chip Model of Epicardial–Myocardial Interaction in Ischemia Reperfusion Injury
Bannerman, D., Pascual‐Gil, S., Wu, Q., Fernandes, I. M., Zhao, Y., Wagner, K. T., Okhovatian, S., Landau, S., Rafatian, N., Bodenstein, D. F., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202302642 · Cited by 31
Self-citationRecreating kidney progenitors from pluripotent cells
Takasato, M., Maier, B., & Little, M. (2013) · Pediatric nephrology (Berlin, West) · doi:10.1007/s00467-013-2592-7 · Cited by 27
“Significant progress has been made in the direct differentiation of hESC/iPSC to specific somatic cell phenotypes, including neurons, cardiomyocytes, pancreatic, and hematopoietic cells [10–13].”
Toya, S. P., Li, F., Bonini, M. G., Gómez, I. L., Mao, M., Bachmaier, K., & Malik, A. B. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.09.041 · Cited by 28
“…their derivatives in different stages of differentiation have been used for cell therapy applications in animal models of cardiovascular disease, 31–33 peripheral vascular disease, 12,34 and central nervous system disorders, 21,22,35,36 their potential in preventing sepsis-induced lung…”
Green, M. D., Huang, S. X. L., & Snoeck, H. (2012) · BioEssays · doi:10.1002/bies.201200090 · Cited by 31
Controllable Expansion of Primary Cardiomyocytes by Reversible Immortalization
Zhang, Y., Nuglozeh, E., Touré, F., Schmidt, A. M., & Vunjak‐Novakovic, G. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.057 · Cited by 27
“VEGF and DKK1 are growth factors used in the cardiovascular differentiation of embryonic stem cells, through stage-specific inhibition of Wnt signaling (Yang et al. , 2008).”
Chow, M. Z. Y., Geng, L., Kong, C., Keung, W., Fung, J. C.-K., Boheler, K. R., & Li, R. A. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0125 · Cited by 27
“A directed differentiation protocol was used to differentiate HES2 into cardiac lineage using the activin A, bone morphogenetic protein-4 (BMP-4), and vascular endothelial growth factor (VEGF) induction, as reported [26].”
Functional Cardiomyocytes Derived from Isl1 Cardiac Progenitors via Bmp4 Stimulation
Çağavi, E., Bártulos, Ó., Suh, C. Y., Sun, B., Yue, Z., Jiang, Z., Yue, L., & Qyang, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110752 · Cited by 32
“Over the last decade, various CPC populations have been suggested based on expression of certain transcription factors or cell surface markers; such as Islet-1 (Isl1+) [2], KDR+ (Flk1) [3], cKit+ lineage- [4], cardiospheres [5, 6], side population cells [7] and Tbx18 epicardial stem cells [8].”
BackgroundPallotta, I., Sun, B. Q., Wrona, E. A., & Freytes, D. O. (2015) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2045 · Cited by 28
Human Stem Cell-Derived Cardiac Model of Chronic Drug Exposure
Nunes, S. S., Feric, N. T., Pahnke, A., Miklas, J. W., Li, M., Coles, J. G., Gagliardi, M., Keller, G. M., & Radisic, M. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00496 · Cited by 28
Self-citationCellular models for human cardiomyopathy: What is the best option?
Jiménez-Téllez, N., & Greenway, S. C. (2019) · World Journal of Cardiology · doi:10.4330/wjc.v11.i10.221 · Cited by 29
Farouz, Y., Chen, Y., Terzic, A., & Menasché, P. (2014) · Stem Cells · doi:10.1002/stem.1929 · Cited by 27
Microscale technologies for regulating human stem cell differentiation
Cimetta, E., & Vunjak‐Novakovic, G. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214530369 · Cited by 26
Kempf, H., & Zweigerdt, R. (2017) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2017_30 · Cited by 29
Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes
Park, M., & Yoon, Y. (2018) · Korean Circulation Journal · doi:10.4070/kcj.2018.0312 · Cited by 28
Xie, H., Hong, N., Zhang, E., Li, F., Sun, K., & Yu, Y. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00015 · Cited by 28
“Additionally, from the network we found that FGF22 directly interact with PDGFRA and KDR which are cardiac progenitor populations with Flk1 in differentiating embryonic stem cells (Kattman et al., 2006; Yang et al., 2008; Kattman et al., 2011).”
BackgroundVertebrate cranial mesoderm: developmental trajectory and evolutionary origin
Vyas, B., Nandkishore, N., & Sambasivan, R. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03373-1 · Cited by 27
Optimizing the Use of iPSC-CMs for Cardiac Regeneration in Animal Models
Bizy, A., & Klos, M. (2020) · Animals · doi:10.3390/ani10091561 · Cited by 26
Perspective: Extending the Utility of Three-Dimensional Organoids by Tissue Clearing Technologies
Susaki, E. A., & Takasato, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.679226 · Cited by 30
“To date, various cell types of target organs have been induced, including those of the blood, myocardium, lung, pancreas, liver, intestine, brain, and kidney (Wang et al., 2007; Davis et al., 2008; Yang et al., 2008; Xia and Zhang, 2009; Spence et al., 2011; Pagliuca et al., 2014; Takasato et al., 2014).”
BackgroundFrom Pluripotency to Distinct Cardiomyocyte Subtypes
David, R., & Franz, W. (2012) · Physiology · doi:10.1152/physiol.00044.2011 · Cited by 29
Nelson, T. J., Chiriac, A. E., Faustino, R. S., Crespo‐Diaz, R. J., Behfar, A., & Terzic, A. (2009) · Differentiation · doi:10.1016/j.diff.2008.10.012 · Cited by 26
“The tyrosine kinase cell surface receptor Flk-1 is a recognized docking site for the vascular endothelial growth factor (VEGF), implicated in broad mesoderm-derived development (Shalaby et al, 1995) and cardiopoiesis (Kattman et al, 2006; Faustino et al, 2008; Yang et al, 2008).”
BackgroundInfluentialPKH26 as a fluorescent label for live human umbilical mesenchymal stem cells
Zhu, S., Zhang, H., Zhi-Nian, Z., & He, Y. (2011) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-011-9424-5 · Cited by 26
“2002), or red fluorescent protein (Yang et al. 2008) are inserted into retrovirus.”
BackgroundDengler, J., Song, H. W., Thavandiran, N., Massé, S., Wood, G. A., Nanthakumar, K., Zandstra, P. W., & Radisic, M. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22987 · Cited by 26
“The ability to generate CMs from either ESCs (Yang et al., 2008) or induced pluripotent stem cells (iPSCs) (Zhang et al.”
BackgroundMethodHuman Pluripotent Stem Cells for Modeling Toxicity
Sison-Young, R. L. C., Kia, R., Heslop, J. A., Kelly, L., Rowe, C., Cross, M. J., Kitteringham, N. R., Hanley, N. A., Park, B. K., & Goldring, C. E. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-398339-8.00006-9 · Cited by 28
Hou, L., Kim, J. J., Wanjare, M., Patlolla, B., Coller, J., Natu, V. S., Hastie, T. J., & Huang, N. F. (2017) · Scientific Reports · doi:10.1038/s41598-017-06986-3 · Cited by 27
Biophysical subsets of embryonic stem cells display distinct phenotypic and morphological signatures
Bongiorno, T., Gura, J. R., Talwar, P., Chambers, D. M., Young, K. M., Arafat, D., Wang, G., Jackson, E., Qiu, P., McDevitt, T. C., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192631 · Cited by 26
Cardiopharyngeal Progenitor Specification: Multiple Roads to the Heart and Head MusclesPreprint
Swedlund, B., & Lescroart, F. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a036731 · Cited by 29
“Modulation of these pathways and others has guided most protocols of differentiation of PSCs toward cardiac lineages (Laflamme et al. 2007; Yang et al. 2008; Kattman et al. 2011).”
BackgroundGhrelin induces cardiac lineage differentiation of human embryonic stem cells through ERK1/2 pathway
Gao, M., Yang, J., Wei, R., Liu, G., Zhang, L., Wang, H., Wang, G., Gao, H., Chen, G., & Hong, T. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.06.106 · Cited by 25
“Recently, it has been regarded as a marker of cardiac progenitor cells [45,46].”
BackgroundRamachandra, C. J. A., Mehta, A. K., Wong, P., & SHIM, W. S. N. (2015) · Stem Cells · doi:10.1002/stem.2223 · Cited by 25
Liu, J., Liu, S., Han, L., Sheng, Y., Zhang, Y., Kim, I., Wan, J., & Yang, L. (2021) · Development · doi:10.1242/dev.199628 · Cited by 26
Self-citationReilly, L., Munawar, S., Zhang, J., Crone, W. C., & Eckhardt, L. L. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.966094 · Cited by 28
Translational aspects of cardiac cell therapy
Chen, C., Sereti, K., Wu, B. M., & Ardehali, R. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12632 · Cited by 28
“While early protocols for differentiating ESCs into cardiomyocytes generated less than 1% yields [93], more recent differentiation protocols have achieved yields of up to 70% [98].”
BackgroundTurner, W. S., Wang, X., Johnson, S. A., Medberry, C. J., Mendez, J., Badylak, S. F., McCord, M., & McCloskey, K. E. (2012) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.32770 · Cited by 25
Shinozawa, T., Imahashi, K., Sawada, H., Furukawa, H., & Takami, K. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112449864 · Cited by 25
“Differentiation of hiPSCs was induced using the method described previously with slight modifications.(20,21) Briefly, the colonies of hiPSCs were isolated in dissociation solution (ReproCELL), and they formed embryoid bodies (EBs) in suspension culture in low cell binding 90 mm dishes (Nunc, Tokyo, Japan) in basic me…”
MethodEpigenetics of induced pluripotency, the seven-headed dragon
Djuric, U., & Ellis, J. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt3 · Cited by 28
“Currently, eff orts are being made to diff erentiate iPS cells and ESCs down diff erent lineages into somatic cell types by recapitulating the in vivo diff erentiation cues in vitro [38,39] (and reviewed in [40]).”
BackgroundCITED2 Cooperates with ISL1 and Promotes Cardiac Differentiation of Mouse Embryonic Stem Cells
Pacheco-Leyva, I., Matias, A. C., Oliveira, D. V., Santos, J. M. A., Nascimento, R., Guerreiro, E. M., Michell, A. C., van de Vrugt, A. M., Machado-Oliveira, G., Ferreira, G. N. M., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.10.002 · Cited by 25
“…the cellular and molecular processes of embryonic development (Blin et al., 2010; Bondue et al., 2008, 2011; Christoforou et al., 2008; Gai et al., 2009; Kattman et al., 2011; Kouskoff et al., 2005; Laugwitz et al., 2005; Moretti et al., 2006; Van Vliet et al., 2012; Yang et al., 2008).”
BackgroundHarnessing cell pluripotency for cardiovascular regenerative medicine
Chen, H., Zhang, A., & Wu, J. C. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0244-8 · Cited by 26
Gage, B. K., Merlin, S., Olgasi, C., Follenzi, A., & Keller, G. M. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110621 · Cited by 26
Self-citationStepwise Clearance of Repressive Roadblocks Drives Cardiac Induction in Human ESCs
Rao, J., Pfeiffer, M. J., Frank, S., Adachi, K., Piccini, I., Quaranta, R., Araúzo-Bravo, M. J., Schwarz, J., Schade, D., Leidel, S. A., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.03.008 · Cited by 27
Directed Differentiation of Human Embryonic Stem Cells to Epidermal Progenitors
Metallo, C. M., Lin, J., de Pablo, J. J., & Palecek, S. P. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-380-0_7 · Cited by 25
“While researchers have identified strategies of obtaining endodermal, mesodermal, and neuroectodermal progenitors from hES cells (3-5), efficient methods of deriving non-neural epithelia have only recently been identified (6,7).”
BackgroundRemuscularizing Failing Hearts with Tissue Engineered Myocardium
Zimmermann, W. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2467 · Cited by 26
Li, S., Cheng, H., Tomaselli, G. F., & Li, R. A. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2013.10.006 · Cited by 24
Microvascularization in 3D Human Engineered Tissue and Organoids
Shin, Y. J., Safina, D., Zheng, Y. Y., & Levenberg, S. (2025) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-103023-115236 · Cited by 25
Nandkishore, N., Vyas, B., Javali, A., Ghosh, S., & Sambasivan, R. (2018) · Development · doi:10.1242/dev.160945 · Cited by 37
“S3A; Mendjan et al., 2014; Yang et al., 2008) for mesoderm induction.”
Background
Metadata
- Authors
- Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., Field, L. J., & Keller, G. M.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Indiana University School of Medicine (US)
- Cornell University (US)
- University Health Network (CA)
- King's College London (GB)
- VistaGen Therapeutics (United States) (US)
- Corresponding author
- Keller, Gordon M.
- ORCID
- Venue
- Nature
- Published
- 2008-04-23
- Volume
- 453
- Issue
- 7194
- Pages
- 524-528
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2010417854
- Cited by
- 1,389
- References
- 30
- Citations by year
- 2026: 17 · 2025: 20 · 2024: 20 · 2023: 33 · 2022: 45 · 2021: 60 · 2020: 65 · 2019: 59 · 2018: 66 · 2017: 89 · 2016: 79 · 2015: 107 · 2014: 114 · 2013: 141 · 2012: 146
- FWCI
- 45.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Lirias (submittedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL079275, R01HL083126)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- human embryonic stem cells, cardiac progenitor cells, KDR, Flk-1, cardiomyocyte differentiation, endothelial differentiation, vascular smooth muscle cell differentiation, mesoderm specification, heart development, embryoid bodies, cell transplantation, cardiac regeneration, cardiovascular tissue engineering, lineage tracing, clonal origin, growth factor cocktail, activin A, BMP4, basic fibroblast growth factor
- MeSH terms
- Cell Differentiation, Cell Line, Humans, Fibroblast Growth Factor 2, Patch-Clamp Techniques, Proto-Oncogene Proteins c-kit, Cell Lineage, Bone Morphogenetic Proteins, Activins, Myocytes, Cardiac, Intercellular Signaling Peptides and Proteins, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor A, Embryonic Stem Cells, Bone Morphogenetic Protein 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.